Investment Thesis
SYNLOGIC is a pre-revenue biopharmaceutical company with zero commercial product sales, negative operating cash flow of -4.4M, and approximately 3-4 quarters of remaining cash runway at current burn rates. While the company maintains a strong balance sheet with 14.7M in cash and no debt, the lack of revenue, ongoing losses, and absence of insider buying activity indicate significant fundamental weakness and uncertainty regarding path to profitability.
Strengths
- Strong liquidity position with 4.30x current ratio and 14.7M cash on hand
- Zero debt burden with 0.00x Debt/Equity ratio
- Stable equity base of 11.9M with low liability burden of 1.4M
Risks
- Zero revenue with 100% YoY decline - pre-revenue stage with no commercialized products
- Negative operating cash flow of -4.4M indicating rapid cash burn and uncertain path to profitability
- Limited cash runway of approximately 3-4 quarters at current burn rate before liquidity depletion
- No insider buying activity in last 90 days suggesting lack of management confidence
- Negative ROE (-8.5%) and ROA (-6.5%) reflect value destruction
Key Metrics to Watch
- Quarterly cash burn rate and remaining cash runway
- Clinical pipeline advancement and regulatory milestones for product candidates
- Time to first commercial revenue event and market acceptance
Financial Metrics
Revenue
0.0
Net Income
-1.0M
EPS (Diluted)
$-0.08
Free Cash Flow
-4.4M
Total Assets
15.4M
Cash
14.7M
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
-8.5%
ROA
-6.5%
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
4.30x
Quick Ratio
4.30x
Debt/Equity
0.00x
Debt/Assets
9.2%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-17T00:57:23.158699 |
Data as of: 2025-12-31 |
Powered by Claude AI